472 related articles for article (PubMed ID: 32699903)
1. Dental Implant Placement in Patients With a History of Medications Related to Osteonecrosis of the Jaws: A Systematic Review.
Sher J; Kirkham-Ali K; Luo JD; Miller C; Sharma D
J Oral Implantol; 2021 Jun; 47(3):249-268. PubMed ID: 32699903
[TBL] [Abstract][Full Text] [Related]
2. Is it safe to place implants in patients at risk of MRONJ?
Owen B; Bradley H
Evid Based Dent; 2021 Jan; 22(3):108-109. PubMed ID: 34561663
[TBL] [Abstract][Full Text] [Related]
3. Dental implants as risk factors for patients with medication-related osteonecrosis of the jaws (MRONJ).
Pichardo SEC; van der Hee JG; Fiocco M; Appelman-Dijkstra NM; van Merkesteyn JPR
Br J Oral Maxillofac Surg; 2020 Sep; 58(7):771-776. PubMed ID: 32631756
[TBL] [Abstract][Full Text] [Related]
4. Oral implant survival in patients with bisphosphonate (BP)/antiresorptive and radiation therapy and their impact on osteonecrosis of the jaws. A systematic review.
Schmitt CM; Buchbender M; Lutz R; Neukam FW
Eur J Oral Implantol; 2018; 11 Suppl 1():S93-S111. PubMed ID: 30109302
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
Grant BT; Amenedo C; Freeman K; Kraut RA
J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
[TBL] [Abstract][Full Text] [Related]
6. Medication-Related Osteonecrosis of the Jaw Around Dental Implants: Implant Surgery-Triggered or Implant Presence-Triggered Osteonecrosis?
Giovannacci I; Meleti M; Manfredi M; Mortellaro C; Greco Lucchina A; Bonanini M; Vescovi P
J Craniofac Surg; 2016 May; 27(3):697-701. PubMed ID: 27092912
[TBL] [Abstract][Full Text] [Related]
7. Clinical and Radiographic Outcomes of Dental Implants in Patients Treated With Antiresorptive Drugs: A Consecutive Case Series.
Otto S; Schnoedt EM; Troeltzsch M; Kaeppler G; Aljohani S; Liebermann A; Fliefel R
J Oral Implantol; 2023 Feb; 49(1):39-45. PubMed ID: 35446931
[TBL] [Abstract][Full Text] [Related]
8. Medication-related Osteonecrosis of the Jaw Induced by Regenerative Therapy in Implant Dentistry: A Scoping Review.
Al-Omari FA; Kuroshima S; Sawase T
J Dent; 2023 Nov; 138():104682. PubMed ID: 37708930
[TBL] [Abstract][Full Text] [Related]
9. Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review.
Kawahara M; Kuroshima S; Sawase T
Int J Implant Dent; 2021 May; 7(1):47. PubMed ID: 33987769
[TBL] [Abstract][Full Text] [Related]
10. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
[TBL] [Abstract][Full Text] [Related]
11. Emerging antiresorptive medications and their potential implications for dental surgeries.
Aminoshariae A; Donaldson M; Horan M; Mackey SA; Kulild JC; Baur D
J Am Dent Assoc; 2022 Jul; 153(7):649-658. PubMed ID: 35277242
[TBL] [Abstract][Full Text] [Related]
12. The effect of antiresorptive drugs on implant therapy: Systematic review and meta-analysis.
Stavropoulos A; Bertl K; Pietschmann P; Pandis N; Schiødt M; Klinge B
Clin Oral Implants Res; 2018 Oct; 29 Suppl 18():54-92. PubMed ID: 30306695
[TBL] [Abstract][Full Text] [Related]
13. Clinical Impact on Dental Implant Survival in Patients Taking Antiresorptive Medications: A Systematic Review and Meta-Analysis.
Ting M; Huynh BH; Woldu HG; Gamal I; Suzuki JB
J Oral Implantol; 2023 Dec; 49(6):599-615. PubMed ID: 37905745
[TBL] [Abstract][Full Text] [Related]
14. The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors.
Dodson TB
Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):509-16. PubMed ID: 26362367
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of medication related osteonecrosis of the jaw in patients treated with sequential antiresorptive drugs: systematic review and meta-analysis.
Srivastava A; Nogueras Gonzalez GM; Geng Y; Won AM; Cabanillas ME; Naing A; Myers JN; Li Y; Chambers MS
Support Care Cancer; 2021 May; 29(5):2305-2317. PubMed ID: 33190182
[TBL] [Abstract][Full Text] [Related]
16. Impact of bisphosphonate therapy on dental implant outcomes: An overview of systematic review evidence.
Mendes V; Dos Santos GO; Calasans-Maia MD; Granjeiro JM; Moraschini V
Int J Oral Maxillofac Surg; 2019 Mar; 48(3):373-381. PubMed ID: 30314708
[TBL] [Abstract][Full Text] [Related]
17. What is the impact of bisphosphonate therapy upon dental implant survival? A systematic review and meta-analysis.
Ata-Ali J; Ata-Ali F; Peñarrocha-Oltra D; Galindo-Moreno P
Clin Oral Implants Res; 2016 Feb; 27(2):e38-46. PubMed ID: 25406770
[TBL] [Abstract][Full Text] [Related]
18. Survival of dental implants among post-menopausal female dental school patients taking oral bisphosphonates: a retrospective study.
Famili P; Quigley S; Mosher T
Compend Contin Educ Dent; 2011; 32(6):E106-9. PubMed ID: 23738968
[TBL] [Abstract][Full Text] [Related]
19. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
[TBL] [Abstract][Full Text] [Related]
20. Development of Antiresorptive Agent-Related Osteonecrosis of the Jaw After Dental Implant Removal: A Case Report.
Yamamoto S; Maeda K; Kouchi I; Hirai Y; Taniike N; Yamashita D; Imai Y; Takenobu T
J Oral Implantol; 2018 Oct; 44(5):359-364. PubMed ID: 29870295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
